GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 11, 2018 at 10:32 AM.

  1. #1 cafead, Dec 11, 2018 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via In the face of "unprecedented" demand for its shingles vaccine, GlaxoSmithKline is doing everything it can to boost supply. But in spite of those efforts—it shipped as much vaccine in the third quarter as it did in the first half of the year—GSK says the Shingrix shortage will persist into 2019.

    article source
     
    Quote

Reply to Thread